Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.
about
RhoD regulates cytoskeletal dynamics via the actin nucleation-promoting factor WASp homologue associated with actin Golgi membranes and microtubulesIdentifying regulational alterations in gene regulatory networks by state space representation of vector autoregressive models and variational annealing.Domain landscapes of somatic mutations in cancer.Sensitivity to TOP2 targeting chemotherapeutics is regulated by Oct1 and FILIP1LThe filamins: organizers of cell structure and functionDown-regulation of Filamin A interacting protein 1-like Is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers [corrected]Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer.Promotion of heat shock factor Hsf1 degradation via adaptor protein filamin A-interacting protein 1-like (FILIP-1L).RNA-sequencing studies identify genes differentially regulated during inflammation-driven lung tumorigenesis and targeted by chemopreventive agents.Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer.Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.Risk factors and biomarkers of age-related macular degeneration.CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer.Polyploidy impairs human aortic endothelial cell function and is prevented by nicotinamide phosphoribosyltransferase.Enhanced antitumor effect of biodegradable cationic heparin-polyethyleneimine nanogels delivering FILIP1LΔC103 gene combined with low-dose cisplatin on ovarian cancer.
P2860
Q24301477-D3A8E177-C6F3-47C3-A609-6E4B29EBB60BQ30457495-2F3BB1AF-8106-4639-B39C-ED315DE5DA09Q34324973-7C913744-26CA-4A8B-B4DB-46D8B224CC9AQ34382668-C6C1581A-01AD-41B7-B731-F7ED94ADB89AQ34891266-A2F5DC43-1FD1-4FA3-A421-89131600617EQ35067854-B8BE46FA-7E1A-4736-BBBA-C8CE0E7F7A50Q35169206-1BDDAB18-407E-4115-8997-6EDDE60FF1D9Q35213186-10DCAE0C-F3D2-4A92-8B0E-F6D9BBBD53DDQ36481857-7839A7B9-2BBA-4BCF-83DC-A514E3B3FA4BQ37684607-2F475F84-C1F7-4185-A246-CF41733DC273Q37687806-BCA8D1D1-E46E-4AD8-9AA1-BDBB7A3654B6Q37710265-97BE8C5E-70E7-470F-8B94-19DBEC210959Q38828895-38CF87FA-B820-47F2-8A7B-FC0197422E12Q43240843-737D4538-2A19-4C17-80BD-369BB1898565Q43257218-5E3DFA9D-6006-4CEF-94DE-35792133B48BQ45873934-D669A1B6-E728-443A-85B6-6B989E5CEF95
P2860
Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional characterization of ...... r antivascular cancer therapy.
@en
Functional characterization of ...... r antivascular cancer therapy.
@nl
type
label
Functional characterization of ...... r antivascular cancer therapy.
@en
Functional characterization of ...... r antivascular cancer therapy.
@nl
prefLabel
Functional characterization of ...... r antivascular cancer therapy.
@en
Functional characterization of ...... r antivascular cancer therapy.
@nl
P2093
P2860
P1433
P1476
Functional characterization of ...... or antivascular cancer therapy
@en
P2093
Christina Stevenson
Dominic Esposito
Dominique Lorang
Engy Hanna
Enrique Zudaire
Frank Cuttitta
John S Quick
Mijung Kwon
P2860
P304
P356
10.1158/0008-5472.CAN-08-1087
P407
P577
2008-09-01T00:00:00Z